Interindividual variability in the prevalence of OPRM1 and CYP2B6 gene variations may identify drug-susceptible populations [PDF]
, 2011 Bunten, Hannah +3 more
core
Reduced Efficacy of d-Amphetamine and 3,4-Methylenedioxymethamphetamine in Inducing Hyperactivity in Mice Lacking the Postsynaptic Scaffolding Protein SHANK1. [PDF]
Front Mol Neurosci, 2018 Sungur AÖ +6 more
europepmc +1 more source
Repeated Administration of D-Amphetamine Induces Distinct Alterations in Behavior and Metabolite Levels in 129Sv and Bl6 Mouse Strains. [PDF]
Front Neurosci, 2018 Vanaveski T +8 more
europepmc +1 more source
Methamphetamine self-administration in humans during D-amphetamine maintenance. [PDF]
J Clin Psychopharmacol, 2014 Pike E +4 more
europepmc +1 more source
Variability in paralimbic dopamine signaling correlates with subjective responses to d-amphetamine. [PDF]
Neuropharmacology, 2016 Smith CT +4 more
europepmc +1 more source
Effects of adolescent exposure to methylmercury and d-amphetamine on reversal learning and an extradimensional shift in male mice. [PDF]
Exp Clin Psychopharmacol, 2017 Boomhower SR, Newland MC.
europepmc +1 more source
Repeated Exposure to D-Amphetamine Decreases Global Protein Synthesis and Regulates the Translation of a Subset of mRNAs in the Striatum. [PDF]
Front Mol Neurosci, 2016 Biever A +6 more
europepmc +1 more source
Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology. [PDF]
J Psychopharmacol, 2016 Smith CT +6 more
europepmc +1 more source
Recent advances in PET measures of brain 5-HT release. [PDF]
J Cereb Blood Flow MetabAgnorelli C +4 more
europepmc +1 more source